Navigation Links
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
Date:2/26/2009

SAN DIEGO, Calif., Feb. 26 /PRNewswire/ -- Accumetrics, Inc. announced today that the Company has appointed Gregory J. Tibbitts, CPA to the position of Chief Financial Officer.

"We believe Greg's extensive experience in both private and public companies will help Accumetrics to advance our financial operations and bring continued success to the Company," says Timothy I. Still, Chief Executive Officer at Accumetrics. "His deep knowledge of the capital markets and the medical device arena will be important as we maximize the commercial opportunity for our technology."

Mr. Tibbitts's background includes 19 years of corporate finance and technical accounting experience balanced between public accounting and private industry. He has held positions with both publicly traded and privately-held companies, with expertise in risk management, treasury, financing and financial operations.

Prior to Accumetrics, Mr. Tibbitts served as Chief Financial Officer of CryoCor, a publicly-traded medical device company, prior to its acquisition by Boston Scientific Corporation. Mr. Tibbitts joined CryoCor in mid-2004, and was heavily involved in both its Initial Public Offering in July 2005 and its ultimate acquisition in 2008 by Boston Scientific. Before joining CryoCor, Mr. Tibbitts served as Chief Financial Officer of Elitra Pharmaceuticals, a privately-held biotechnology company, and as a Senior Manager in the audit practice of Ernst & Young LLP.

Mr. Tibbitts received a BBA degree from the University of San Diego, and an MBA from San Diego State University, and serves on the Board of Directors of IDMI Pharmaceuticals, a publicly-traded biotechnology company.

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet response and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

    CONTACT:    Jules Abraham
                Lippert Heilshorn & Associates
                212-838-3777
                jabraham@lhai.com

                Timothy I. Still
                Accumetrics
                press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Gregory Sawyer, of Los Gatos, Has Been Selected by the American Dental Association for the Evidence-Based Dentistry Champion Conference
2. MDdatacor Names Gregory Buchholz Chief Operating Officer
3. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer
4. Congressman Gregory W. Meeks to Ask for Suspension of CARES Process at the St. Albans Veteran Campus
5. Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer
6. Gregory A. Adams Named Northern California Region President of Kaiser Foundation Health Plan and Hospitals
7. Dr. Gregory Buford and Top Plastic Surgeon Selected as a Keynote Speaker at Spa & Resort Expo LA Convention Center, February 23-25
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brickson Diamond Appointed Board Chair of National Hospice Foundation
10. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
11. Margaret Laub Appointed to IntelliDOT Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: